Oxidative stress in the brain at early preclinical stages of mouse scrapie

Experimental Neurology

Volumn 201, Issue 1, 2006, Pages 90-98

  Yun, Seong Wook ^a   Gerlach, Manfred ^b   Riederer, Peter ^a   Klein, Michael A ^c  

^a Excellence Research Laboratories   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Heme oxygenase 1; Lipid peroxidation; Oxidative stress; Prion disease; Scrapie; Synaptophysin

Indexed keywords

ALKENE DERIVATIVE; BIOLOGICAL MARKER; HEME OXYGENASE 1; LIPID; MALONALDEHYDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN DEGENERATION; BRAIN FUNCTION; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MARKER; DISEASE MODEL; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE; SYNAPTIC INHIBITION; VIRUS VIRULENCE;

ALDEHYDES; ANIMALS; BLOTTING, WESTERN; BRAIN; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HEME OXYGENASE-1; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCRAPIE; SYNAPTOPHYSIN; TIME FACTORS;

EID: 33747093723     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.03.025     Document Type: Article

References (74)

1. Andreoletti O., Levavasseur E., Uro-Coste E., Tabouret G., Sarradin P., Delisle M.B., Berthon P., Salvayre R., Schelcher F., and Negre-Salvayre A. Astrocytes accumulate 4-hydroxynonenal adducts in murine scrapie and human Creutzfeldt-Jakob disease. Neurobiol. Dis. 11 (2002) 386-393
2. Baranano D.E., Rao M., Ferris C.D., and Snyder S.H. Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16093-16098
3. Barja G. Free radicals and aging. Trends Neurosci. 27 (2004) 595-600
4. Barmada S., Piccardo P., Yamaguchi K., Ghetti B., and Harris D.A. GFP-tagged prion protein is correctly localized and functionally active in the brains of transgenic mice. Neurobiol. Dis. 16 (2004) 527-537
5. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radical Biol. Med. 32 (2002) 797-803
6. Begara-McGorum I., Gonzalez L., Simmons M., Hunter N., Houston F., and Jeffrey M. Vacuolar lesion profile in sheep scrapie: factors influencing its variation and relationship to disease-specific PrP accumulation. J. Comp. Pathol. 127 (2002) 59-68
7. Boehning D., and Snyder S.H. Novel neural modulators. Annu. Rev. Neurosci. 26 (2003) 105-131
8. Brown D.R., Schulz-Schaeffer W.J., Schmidt B., and Kretzschmar H.A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146 (1997) 104-112
9. Brown D.F., Risser R.C., Bigio E.H., Tripp P., Stiegler A., Welch E., Eagan K.P., Hladik C.L., and White Jr. C.L. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. J. Neuropathol. Exp. Neurol. 57 (1998) 955-960
10. Budka H. Neuropathology of prion diseases. Br. Med. Bull. 66 (2003) 121-130
11. Butterfield D.A., and Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radical Biol. Med. 32 (2002) 1050-1060
12. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., Rostaing P., Triller A., Salem Jr. N., Ashe K.H., Frautschy S.A., and Cole G.M. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43 (2004) 633-645
13. Carrie I., Clement M., de Javel D., Frances H., and Bourre J.M. Specific phospholipid fatty acid composition of brain regions in mice. Effects of n-3 polyunsaturated fatty acid deficiency and phospholipid supplementation. J. Lipid Res. 41 (2000) 465-472
14. Chen K., Gunter K., and Maines M.D. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J. Neurochem. 75 (2000) 304-313
15. Choi S.I., Ju W.K., Choi E.K., Kim J., Lea H.Z., Carp R.I., Wisniewski H.M., and Kim Y.S. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol. (Berl.) 96 (1998) 279-286
16. Choi Y.G., Kim J.I., Lee H.P., Jin J.K., Choi E.K., Carp R.I., and Kim Y.S. Induction of heme oxygenase-1 in the brains of scrapie-infected mice. Neurosci. Lett. 289 (2000) 173-176
17. Clinton J., Forsyth C., Royston M.C., and Roberts G.W. Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. NeuroReport 4 (1993) 65-68
18. Coleman P., Federoff H., and Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63 (2004) 1155-1162
19. Colombrita C., Calabrese V., Stella A.M., Mattei F., Alkon D.L., and Scapagnini G. Regional rat brain distribution of heme oxygenase-1 and manganese superoxide dismutase mRNA: relevance of redox homeostasis in the aging processes. Exp. Biol. Med. (Maywood) 228 (2003) 517-524
20. Cunningham C., Deacon R., Wells H., Boche D., Waters S., Diniz C.P., Scott H., Rawlins J.N., and Perry V.H. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur. J. Neurosci. 17 (2003) 2147-2155
21. Fernaeus S., Reis K., Bedecs K., and Land T. Increased susceptibility to oxidative stress in scrapie-infected neuroblastoma cells is associated with intracellular iron status. Neurosci. Lett. 389 (2005) 133-136
22. Fernaeus S., Halldin J., Bedecs K., and Land T. Changed iron regulation in scrapie-infected neuroblastoma cells. Brain Res. Mol. Brain Res. 133 (2005) 266-273
23. Ferrer I., Rivera R., Blanco R., and Marti E. Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease. Neurobiol. Dis. 6 (1999) 92-100
24. Ferri A., Sanes J.R., Coleman M.P., Cunningham J.M., and Kato A.C. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol. 13 (2003) 669-673
25. Fournier J.G., Escaig-Haye F., and Grigoriev V. Ultrastructural localization of prion proteins: physiological and pathological implications. Microsc. Res. Tech. 50 (2000) 76-88
26. Gerlach M., Ben-Shachar D., Riederer P., and Youdim M.B. Altered brain metabolism of iron as a cause of neurodegenerative diseases?. J. Neurochem. 63 (1994) 793-807
27. Gibson G.E., and Huang H.M. Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease. Front. Biosci. 7 (2002) d1007-d1015
28. Glatzel M., Heppner F.L., Albers K.M., and Aguzzi A. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31 (2001) 25-34
29. Gotz M.E., Double K., Gerlach M., Youdim M.B., and Riederer P. The relevance of iron in the pathogenesis of Parkinson's disease. Ann. N. Y. Acad. Sci. 1012 (2004) 193-208
30. Guentchev M., Voigtlander T., Haberler C., Groschup M.H., and Budka H. Evidence for oxidative stress in experimental prion disease. Neurobiol. Dis. 7 (2000) 270-273
31. Herms J., Tings T., Gall S., Madlung A., Giese A., Siebert H., Schurmann P., Windl O., Brose N., and Kretzschmar H. Evidence of presynaptic location and function of the prion protein. J. Neurosci. 19 (1999) 8866-8875
32. 2 production and lipid and protein oxidative damage. Mech. Ageing Dev. 122 (2001) 427-443
33. Honer W.G. Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals. Neurobiol. Aging 24 (2003) 1047-1062
34. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
35. Jeffrey M., Halliday W.G., Bell J., Johnston A.R., MacLeod N.K., Ingham C., Sayers A.R., Brown D.A., and Fraser J.R. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol. Appl. Neurobiol. 26 (2000) 41-54
36. Johnson R.T., and Gibbs Jr. C.J. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N. Engl. J. Med. 339 (1998) 1994-2004
37. Johnston A.R., Fraser J.R., Jeffrey M., and MacLeod N. Synaptic plasticity in the CA1 area of the hippocampus of scrapie-infected mice. Neurobiol. Dis. 5 (1998) 188-195
38. Kim N.H., Park S.J., Jin J.K., Kwon M.S., Choi E.K., Carp R.I., and Kim Y.S. Increased ferric iron content and iron-induced oxidative stress in the brains of scrapie-infected mice. Brain Res. 884 (2000) 98-103
39. Kim J.I., Choi S.I., Kim N.H., Jin J.K., Choi E.K., Carp R.I., and Kim Y.S. Oxidative stress and neurodegeneration in prion diseases. Ann. N. Y. Acad. Sci. 928 (2001) 182-186
40. Kimberlin R.H., and Walker C.A. Pathogenesis of mouse scrapie: evidence for neural spread of infection to the CNS. J. Gen. Virol. 51 (1980) 183-187
41. Koeppen A.H., Dickson A.C., and Smith J. Heme oxygenase in experimental intracerebral hemorrhage: the benefit of tin-mesoporphyrin. J. Neuropathol. Exp. Neurol. 63 (2004) 587-597
42. Lasmezas C.I., Deslys J.P., Robain O., Jaegly A., Beringue V., Peyrin J.M., Fournier J.G., Hauw J.J., Rossier J., and Dormont D. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275 (1997) 402-405
43. Lee D.W., Sohn H.O., Lim H.B., Lee Y.G., Kim Y.S., Carp R.I., and Wisniewski H.M. Alteration of free radical metabolism in the brain of mice infected with scrapie agent. Free Radical Res. 30 (1999) 499-507
44. Liu D., Wen J., Liu J., and Li L. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein. DNA, and membrane phospholipids. FASEB J. 13 (1999) 2318-2328
45. Lu T., Pan Y., Kao S.Y., Li C., Kohane I., Chan J., and Yankner B.A. Gene regulation and DNA damage in the ageing human brain. Nature 429 (2004) 883-891
46. Mallucci G., Dickinson A., Linehan J., Klohn P.C., Brandner S., and Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302 (2003) 871-874
47. McMahon H.E., Mange A., Nishida N., Creminon C., Casanova D., and Lehmann S. Cleavage of the amino terminus of the prion protein by reactive oxygen species. J. Biol. Chem. 276 (2001) 2286-2291
48. Mehindate K., Sahlas D.J., Frankel D., Mawal Y., Liberman A., Corcos J., Dion S., and Schipper H.M. Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J. Neurochem. 77 (2001) 1386-1395
49. Milhavet O., and Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res. Brain Res. Rev. 38 (2002) 328-339
50. Minghetti L., Greco A., Cardone F., Puopolo M., Ladogana A., Almonti S., Cunningham C., Perry V.H., Pocchiari M., and Levi G. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J. Neuropathol. Exp. Neurol. 59 (2000) 866-871
51. Miyashita M., Stierstorfer B., and Schmahl W. Neuropathological findings in brains of Bavarian cattle clinically suspected of bovine spongiform encephalopathy. J. Vet. Med., B Infect. Dis. Vet. Public Health 51 (2004) 209-215
52. Nicolle M.M., Gallagher M., and McKinney M. No loss of synaptic proteins in the hippocampus of aged, behaviorally impaired rats. Neurobiol. Aging 20 (1999) 343-348
53. Oxenkrug G.F., and Requintina P.J. Mating attenuates aging-associated increase of lipid peroxidation activity in C57BL/6J mice. Ann. N. Y. Acad. Sci. 993 (2003) 161-167
54. Petersen R.B., Siedlak S.L., Lee H.G., Kim Y.S., Nunomura A., Tagliavini F., Ghetti B., Cras P., Moreira P.I., Castellani R.J., Guentchev M., Budka H., Ironside J.W., Gambetti P., Smith M.A., and Perry G. Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol. (Berl.) 110 (2005) 232-238
55. Poon H.F., Calabrese V., Scapagnini G., and Butterfield D.A. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 59 (2004) 478-493
56. Poon H.F., Calabrese V., Scapagnini G., and Butterfield D.A. Free radicals and brain aging. Clin. Geriatr. Med. 20 (2004) 329-359
57. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., and Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21 (2001) 4183-4187
58. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
59. Ramassamy C., Krzywkowski P., Averill D., Lussier-Cacan S., Theroux L., Christen Y., Davignon J., and Poirier J. Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. Brain Res. Mol. Brain Res. 86 (2001) 76-83
60. Requena J.R., Groth D., Legname G., Stadtman E.R., Prusiner S.B., and Levine R.L. Copper-catalyzed oxidation of the recombinant SHa(29-231) prion protein. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 7170-7175
61. Russelakis-Carneiro M., Hetz C., Maundrell K., and Soto C. Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts. Am. J. Pathol. 165 (2004) 1839-1848
62. Satoh T., Baba M., Nakatsuka D., Ishikawa Y., Aburatani H., Furuta K., Ishikawa T., Hatanaka H., Suzuki M., and Watanabe Y. Role of heme oxygenase-1 protein in the neuroprotective effects of cyclopentenone prostaglandin derivatives under oxidative stress. Eur. J. Neurosci. 17 (2003) 2249-2255
63. Schipper H.M. Heme oxygenase expression in human central nervous system disorders. Free Radical Biol. Med. 37 (2004) 1995-2011
64. Shiraishi N., Inai Y., Bi W., and Nishikimi M. Fragmentation and dimerization of copper-loaded prion protein by copper-catalysed oxidation. Biochem. J. 387 (2005) 247-255
65. Siso S., Puig B., Varea R., Vidal E., Acin C., Prinz M., Montrasio F., Badiola J., Aguzzi A., Pumarola M., and Ferrer I. Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol. (Berl.) 103 (2002) 615-626
66. Snyder S.H., and Baranano D.E. Heme oxygenase: a font of multiple messengers. Neuropsychopharmacology 25 (2001) 294-298
67. Sung S., Yao Y., Uryu K., Yang H., Lee V.M., Trojanowski J.Q., and Pratico D. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J. 18 (2004) 323-325
68. Takahashi T., Morita K., Akagi R., and Sassa S. Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr. Med. Chem. 11 (2004) 1545-1561
69. Thackray A.M., Klein M.A., Aguzzi A., and Bujdoso R. Chronic subclinical prion disease induced by low-dose inoculum. J. Virol. 76 (2002) 2510-2517
70. Thackray A.M., Klein M.A., and Bujdoso R. Subclinical prion disease induced by oral inoculation. J. Virol. 77 (2003) 7991-7998
71. Viles J.H., Cohen F.E., Prusiner S.B., Goodin D.B., Wright P.E., and Dyson H.J. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2042-2047
72. Wiedenmann B., and Franke W.W. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41 (1985) 1017-1028
73. Wong B.S., Liu T., Li R., Pan T., Petersen R.B., Smith M.A., Gambetti P., Perry G., Manson J.C., Brown D.R., and Sy M.S. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J. Neurochem. 76 (2001) 565-572
74. Zou L., Xu J., Jankovic J., He Y., Appel S.H., and Le W. Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice. Neurosci. Lett. 281 (2000) 167-170